Breast Cancer
Ribociclib regimen continues to show survival benefit in postmenopausal breast cancer
The addition of ribociclib to fulvestrant conferred a survival benefit of nearly 16 months as first-line treatment for postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer, topline data showed.
AYA cancer survivors at higher risk for death due to second primary cancers
Death due to a second primary cancer occurred nearly twice as often among adolescent and young adult cancer survivors compared with the general population, according to study results published in Journal of the National Cancer Institute.
Men with breast cancer ‘deserve attention,’ may benefit from surgery for stage IV disease
Surgery with systemic therapy improved survival among men with stage IV breast cancer and known ER and PR status, according to study results published in Annals of Surgical Oncology.
VIDEO: Stephanie Faubion, MD, reports on latest updates in women’s health
CHICAGO — In this video interview with Healio, Stephanie Faubion, MD, MBA, FACP, NCMP, IF, highlights recent research on women’s health, which she discussed during her presentation here.
Exploring the PAVING Program for Breast Cancer Survivors
In this episode, Amy Comander, MD, Beth Frates, MD, and Michelle Tollefson, MD, discuss their journeys in the breast cancer treatment and awareness space and their new personal well-being resource, PAVING the Path to Wellness Workbook.
Top in hem/onc: Vitamin D deficiency and breast cancer risk; the perpetual ‘yes’
A recent study found that individuals from underrepresented populations with vitamin D deficiency may be at a higher risk for breast cancer.
Enhertu receives breakthrough therapy designation for breast cancer subset
The FDA granted breakthrough therapy designation to fam-trastuzumab deruxtecan-nxki for treatment of adults with unresectable or metastatic HER2-low breast cancer, according to a press release from the agent’s manufacturer.
Black, Hispanic women with vitamin D deficiency may be at higher risk for breast cancer
Black/African American and Hispanic/Latina women who have low vitamin D concentrations may be more likely to be diagnosed with breast cancer than those with adequate concentrations, according to a study published in Cancer.
VIDEO: Evolutions in HER2-targeted therapies for breast cancer
In this video, Debu Tripathy, MD, discussed developments in HER2-positive breast cancer targeted treatments, including antibody-drug conjugates, which were reviewed at 39th Miami Breast Cancer Conference.
Aromatase inhibitors reduce breast cancer recurrence vs. tamoxifen for certain women
Use of an aromatase inhibitor instead of tamoxifen reduced the risk for breast cancer recurrence among premenopausal women with ER-positive disease who received ovarian suppression, according to a study published in The Lancet Oncology.